Diabetes Therapy to Improve BMI and Lung Function in CF - Contacts and Locations

Diabetes Therapy to Improve BMI and Lung Function in CF

This study has been completed.

Study NCT00072904. Last updated on December 20, 2007. Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00072904

Locations


United States, California
	Stanford University
	Palo Alto, California, United States, 94304

United States, Massachusetts
	Baystate Medical Center
	Springfield, Massachusetts, United States, 01199

United States, Minnesota
	University of Minnesota Medical Center
	Minneapolis, Minnesota, United States, 55455

United States, Pennsylvania
	Children's Hospital of Pittsburgh
	Pittsburgh, Pennsylvania, United States, 15213-2583

United States, Tennessee
	Vanderbilt University Medical Center
	Nashville, Tennessee, United States, 37232-2650

United States, Utah
	University of Utah
	Salt Lake City, Utah, United States, 84132-4701

Canada, Ontario
	St. Michael's Hospital
	Toronto, Ontario, Canada, M5B 1W8

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Cystic Fibrosis Foundation

Novo Nordisk

Investigators


Principal Investigator:	Antoinette Moran, MD	University of Minnesota